0.05 | 1.00%
| Price and Volume | |
|---|---|
| Recent Price | 5.04 |
| 52 Week High | 9.20 |
| 52 Week Low | 4.45 |
| Avg. Daily Vol. (Mil) | 0.03 |
| Beta (3 year) | 0.28 |
| Share Related Items | |
| Mkt Cap (Mil) | 132.34 |
| Shares Out (Mil) | 26.26 |
| Float (Mil) | 8.52 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 2.20 |
| Current Ratio | 2.70 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 1.41 |
| Price/Book | 0.76 |
| Price/Cash Flow | 10.70 |
| Per Share Data | |
| Earnings | -0.17 |
| Sales | 3.56 |
| Book Value | 6.61 |
| Cash Flow | 0.47 |
| Business Summary | |
|---|---|
| Cornerstone Therapeutics Inc. is a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products mainly for the respiratory and related markets. | |
| General Information | |
| 1255 Crescent Green Drive
Suite 250 Cary, NC 27518 |
|
| www.crtx.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 116 | |
| CEO: Mr. Craig A. Collard | |
| Short Interest | |
| Current Month (Mil) | 0.25 |
| Previous Month (Mil) | 0.24 |
| Short Interest Ratio (Days) | 9.00 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -1.90 |
| Return on Investments | -2.50 |
| Profitability | |
| Gross Margin | 59.00 |
| EBIT Margin | -7.30 |
| Profit Margin | -4.60 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,454.83 | 1,317.82 | 2,837.53 | 17.45 |
Oil *
106.76
|
|
DOWN
74.92 |
DOWN
2.86 |
DOWN
1.85 |
DOWN
0.14 |
10 Yr
1.74%
SPDR Gold
152.68
|
|
-0.60%
|
-0.22%
|
-0.07%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet